| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf7439808d578ab8c3698f7560fe4ab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002 |
| filingDate |
2014-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cca19e933eec4c8c5cbdf029d05a81aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6e961f15ecb6748392bd009f1cd92b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5804d9b5d467e1e7248feb4036f5e74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_187291ad7557e8b67fd24cfb8af2189d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcd69a10404353555ca3a08ba15d66c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9869d1e9c00e026177c5727d105d1101 |
| publicationDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016000895-A1 |
| titleOfInvention |
Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection |
| abstract |
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or morality associated with subsequent infection are provided herein. The vaccine vectors include a polynucleotide encoding a Rhomboid polypeptide and optionally include an immune-stimulatory polypeptide suitably expressed on the surface of the vaccine vector. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015216954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382962-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884099-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328137-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364290-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016493-B2 |
| priorityDate |
2013-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |